DALLAS, Feb. 11, 2026 (GLOBE NEWSWIRE) — Spring Valley Acquisition Corp. IV (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced the closing of its initial public offering of 23,000,000 units at a price of $10.00 per unit on February 11, 2026, which includes the exercise in full by the underwriters of their overallotment option to purchase an additional 3,000,000 units. Total gross proceeds from the offering were $230 million before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The units began trading on The Nasdaq Global Market (“Nasdaq”) under the ticker symbol “SVIVU” on February 10, 2026. Each unit consists...

RICHMOND, Va., Feb. 11, 2026 (GLOBE NEWSWIRE) — ARKO Corp. (Nasdaq: ARKO) (“ARKO”) and ARKO Petroleum Corp., a subsidiary of ARKO (“APC”), today announced the pricing of APC’s initial public offering (the “IPO”) of 11,111,111 shares of its Class A common stock at a price to the public at $18.00 per share (the “IPO Price”). In addition, APC has granted the underwriters a 30-day option to purchase up to an additional 1,666,666 shares of APC’s Class A common stock to cover over-allotments, if any, at the IPO Price, less underwriting discounts and commissions. APC’s Class A common stock has been approved for listing on the Nasdaq Capital Market (“Nasdaq”) under the symbol “APC” and is expected to begin trading on February 12, 2026. The IPO is expected to close on February 13, 2026, subject to customary closing conditions. Upon the...

Hong Kong, Feb. 11, 2026 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (Nasdaq: AXG) (“AXG” or the “Company”), a leading financial technology firm bridging traditional and digital assets, today announced that it has entered into a securities purchase agreement with Streeterville Capital, LLC (“Streeterville”) for up to US$100 million in financing. Under the agreement, the Company will issue and sell to Streeterville one or more pre-paid purchases with an aggregate purchase price of up to US$100 million for the purchase of AXG’s class A ordinary shares. The initial pre-paid purchase of approximately US$5.415 million (before deducting an original issue discount and transaction expenses) has been completed. Additional pre-paid purchases may be made upon mutual consent of the parties. The proceeds are expected to be used primarily to support...

RADNOR, Pa., Feb. 11, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today that on February 9, 2026, the Compensation Committee of Mineralys’ Board of Directors granted inducement stock option awards covering 33,504 shares and inducement restricted stock unit awards covering 25,128 shares of Mineralys common stock to two new non-executive employees. The awards were granted under Mineralys’ 2025 Employment Inducement Incentive Award Plan, which provides for the granting of equity awards to new employees of Mineralys. The options will vest over a four-year...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA Allied’s base shelf prospectus, and the shelf prospectus supplement for the public offering, will be accessible, within two business days, through SEDAR+ TORONTO, Feb. 11, 2026 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (TSX:AP.UN) (“Allied”) announced today that it has priced and upsized its previously announced marketed public offering (the “Offering”) and concurrent private placement (the “Private Placement”). The Offering now comprises an aggregate of 40,000,000 units of Allied (the “Units”) at a price of $10.00 per Unit (the “Offering Price”) for aggregate gross proceeds of $400,000,000, representing an increase from the initial offering size of approximately $350,000,000. In connection with the Private...

HIGHLIGHTS11,025 m of infill drilling completed (5,043 m new results) on 10-m drill spacing in 116 drill holes from August 2025 representing ~80% of the total planned ~13 km infill program Highlight intercepts include: 596.40 g/t Au over 2.0 m from 6.1 m downhole (including 2,293.56 g/t Au over 0.5 m from 6.6 m downhole), 21.67 g/t Au over 3.5 m from 96.5 m downhole (including 135.44 g/t Au over 0.5 m from 99.5 m downhole), and 21.97 g/t Au over 2.5 m from 48.7 m downhole Results to date continue to contribute to a more detailed understanding of spatial controls and local variability of the Lowhee Zone An aggregate total of ~12.1 km (~88%) of total planned drill meters have been completed to date, with full assays and QA/QC pending for the remaining, unreported holes Infill program anticipated to conclude in early Q2 2026MONTREAL,...

New York, Feb. 11, 2026 (GLOBE NEWSWIRE) — XFLH Capital Corporation, a Cayman Islands exempt company (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at an offering price of $10.00 per unit. The Company’s units are expected to be listed on the New York Stock Exchange (“NYSE”) and trade under the ticker symbol “XFLHU” beginning on February 12, 2026. Each unit consists of one ordinary share, par value $0.0001 per share, and one right to receive one-seventh (1/7) of an ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the shares and rights are expected to be listed on NYSE under the symbols “XFLH”, and “XFLHR”, respectively. Maxim Group LLC is acting as the sole book-running manager for the offering....

NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided data presented at the February 2026 Tandem Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for Blood and Marrow Transplant Research (CIBMTR) in Salt Lake City, Utah. The study results showed that Ryoncil® (remestemcel-L-rknd) achieved similarly high survival outcomes in steroid-refractory acute graft-versus-host disease (SR-aGvHD) irrespective whether used in children or adults, as second or third line, and in ruxolitinib naive or resistant patients.1 Ryoncil® is the first mesenchymal stromal cell (MSC) product approved by the U.S. Food and Drug Administration (FDA) for any indication, and the only product approved...

RYE, N.Y., Feb. 11, 2026 (GLOBE NEWSWIRE) — The Board of Trustees of The Gabelli Global Small and Mid Cap Value Trust (NYSE:GGZ) (the “Fund”) declared a $0.21 per share cash distribution payable on March 24, 2026 to common shareholders of record on March 17, 2026. This is a 31% increase from $0.16 per share, bringing the annualized distribution rate to $0.84 from $0.64 per share. The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for regulated investment companies, the Fund may pay an adjusting distribution in December which includes any additional income and net realized capital gains in excess of the quarterly distributions for that year. Each...

HOUSTON, Feb. 11, 2026 (GLOBE NEWSWIRE) — Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) (the “Company”) today announces its preliminary, unaudited Q4 2025 operational highlights and guidance for 2026. CEO Commentary “2025 marked another exceptional year for Itafos. Operating in a safe manner is our first priority, and I am proud to report that the Company had no reportable environmental releases and a Total Recordable Incident Frequency Rate (“TRIFR”) of 0.56, down from 0.86 in 2024”, said David Delaney, Chief Executive Officer of the Company. “At Conda, we maintained our US industry-leading operating rates, increasing production on a P2O5 basis compared to 2024 and setting a new full-year plant production record under Itafos ownership. We finished mining at our Rasmussen Valley mine and achieved mechanical completion of the infrastructure...